Ann: Proteomics bolsters executive team - CCO and CFO appointed, page-78

Owl and Juju, be careful what you are implying.

As you would remember Owl, when I used to hold PIQ I was super critical of the company progress and management. As one bloody well should be if their company seemingly makes little progress and management is wishy washy on their strategy. Nothing wrong with being critical and assessing risks.

For full disclosure, I am super critical on all stocks I own, and stocks I am looking to invest in. I do recognise positives also, but sometimes the negatives and risks are almost as important to consider. I have learnt that downplaying or disregarding risks can be dangerous and can result in loss of capital or profit erosion.

As for the recent price action, I've not provided any commentary on it other than to say I sold out of PIQ at a level not too far from current, so not too sure what you are implying there. The price action is what it is, but that shouldn't get in the way of discussing the fundamentals of the company.

If you want to talk charting, happy to do so. It's pointless getting the cheer squad out when the price is still 50% down from recent highs. I've seen far too often when the cheers squad comes out on an up day, the stock price plummets again and the cheers squad is gone quicker than they arrived. For you investors, the long term price is the one that matters. The long term price is guided only by fundamentals, and that is why I have returned to PIQ to query outstanding concerns of the company fundamantals before deploying capital.